Development of an Arabic Central Auditory Processing Remediation Program for Dyslexic Children With(C)APD

Sponsor
Rana ElShafaei (Other)
Overall Status
Recruiting
CT.gov ID
NCT04708899
Collaborator
Alexandria University (Other)
50
1
2
23
2.2

Study Details

Study Description

Brief Summary

Rehabilitation of dyslexic children with (cental) auditory processing disorder.

The first group will receive the proposed program the arabic version of differential processing training program and the control group will receive the computer based auditory traing program (CBAT).

Condition or Disease Intervention/Treatment Phase
  • Behavioral: arabic version of differential processing training program
  • Behavioral: Arabic computer based auditory traing program(CBAT)
N/A

Detailed Description

Central Auditory Processing Disorder(C)APD is defined as difficulty for children with normal hearing to listen selectively in the presence of noise, to combine information from two ears properly, to process speech when it is slightly degraded, and to integrate auditory information when it is delivered faster than the individual with (C)APD can process.( The estimated prevalence of (C)APD in the school-aged population is approximately 2 to 5 %, and the estimated prevalence of (C)APD in the older adult population is 76 %. These percentages are higher than those affected by hearing loss.

Dyslexia and (C)APD are common comorbidities and since there is limited research on (C)APD within each related academic discipline. Furthermore the language, audiologiological , and cognitive nature of the disorder confirmed that a multi-disciplinary effort is needed in order to provide clinical decision and effective intervention for the (C)APD population. Hence Development of additional intervention tools for use in clinics, schools and home settings is warranted .

The aim of this work is to develop a novel Arabic (C)APD remediation program ,to study the outcome of the program and to validate it's effectiveness by comparing it to the Arabic computer based auditory training(CBAT) program.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
50 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Intervention Model Description:
Rehabilitation of dyslexic children with (cental) auditory processing disorder. The first group will receive the proposed program the arabic version of differential processing training program and the control group will receive the computer based auditory traing program (CBAT).Rehabilitation of dyslexic children with (cental) auditory processing disorder. The first group will receive the proposed program the arabic version of differential processing training program and the control group will receive the computer based auditory traing program (CBAT).
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
Development of an Arabic Central Auditory Processing Remediation Program for Dyslexic Children With(Central) Auditory Processing Disorder
Anticipated Study Start Date :
Jan 1, 2021
Anticipated Primary Completion Date :
Jun 1, 2022
Anticipated Study Completion Date :
Dec 1, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Cases

cases will receive the proposed program(the arabic version of differential processing training program)

Behavioral: arabic version of differential processing training program
comprehensive training program for central auditory processing disorder contains auditory and linguistic tasks (language organization, phonemic and phonetic awareness, dichotic listening,temporal patterning and auditory discrimination).

Active Comparator: control

controls will receive the computer based auditory training program (CBAT)

Behavioral: Arabic computer based auditory traing program(CBAT)
comprehensive computer based traing program for central auditory processing disorder contains auditory memory, temporal processing, dichotic listening , selective attention and phonemic awareness games.

Outcome Measures

Primary Outcome Measures

  1. Improvement in dichotic listening [within 6 months]

    assessed by screening and full version dichotic digits test pretherapy and post therapy

  2. Improvement in speech discrimination in noise. [Within 6 months]

    assesed by screening and full version(auditory figure ground) SPIN test pretherapy and post therapy

  3. Improvement in temporal processing [within 6 months]

    assessed by screening and full version pitch pattern sequence test (PPST) pretherapy and post therapy

Secondary Outcome Measures

  1. improvement in phonological processing and awareness skills [within 6month to 1 year]

    assessed by phonological awareness assessment pretherapy and post therapy

Eligibility Criteria

Criteria

Ages Eligible for Study:
6 Years to 12 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  1. dyslexic children with (C)APD

  2. Age from 6-12 years.

  3. No gender limit.

  4. Normal peripheral hearing i.e pure tone averages (average threshold from 250to 8000 Hz) should be less than or equal 25dB hearing level bilaterally.

  5. Normal speech audiometry results.

  6. Normal results on immitancemetry.

  7. Average or below average IQ.

  8. Normal language development.

Exclusion Criteria:
  1. ADHD subjects. 2. Associated neurological and psychiatric disorders.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Alexandria university Alexandria Azarita Egypt 21311

Sponsors and Collaborators

  • Rana ElShafaei
  • Alexandria University

Investigators

  • Study Chair: Hesham kozou, Professor, Alexandria University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Rana ElShafaei, assistant lecturer of Phoniatrics (otorhinolaryngology department), Alexandria University
ClinicalTrials.gov Identifier:
NCT04708899
Other Study ID Numbers:
  • 00018699
First Posted:
Jan 14, 2021
Last Update Posted:
Jan 14, 2021
Last Verified:
Jan 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jan 14, 2021